Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Global X Data Center & Digital Infra ETF (DTCR) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance

Global X Data Center & Digital Infra ETFTrade
Iovance Biotherapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Global X Data Center & Digital Infra ETF vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Global X Data Center & Digital Infra ETF trades at $27.65 (market cap $2.04B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.63 (market cap $6.04B). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 3× Global X Data Center & Digital Infra ETF's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Global X Data Center & Digital Infra ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Global X Data Center & Digital Infra ETF for 15 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.

DTCRIOVA
Market Cap
$2.04B$6.04B
Volume
899,53214,805,993
Sector
Sector/ThematicHealth
52-Week High
$32.46$14.82
52-Week Low
$19.73$1.81
Typical Hold Time
15 Days0 Days
Enterprise Value
—$5.97B

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DTCR
100% Buy0% Sell
Avg holding period · 15 Days
IOVA
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Global X Data Center & Digital Infra ETF

Global X Data Center & Digital Infrastructure ETF seeks exposure to companies involved in data centers and digital infrastructure. Its holdings span areas such as digital infrastructure, networking, and related real estate.

Read more on DTCR →

About Iovance Biotherapeutics Inc. Common Stock

Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.

Read more on IOVA →